Skoda RC - Search Results

1

Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNs.

Duek A, Lundberg P, Shimizu T, Grisouard J, Karow A, Kubovcakova L, Hao-Shen H, Dirnhofer S, Skoda RC. Duek A, et al. Among authors: skoda rc. Blood. 2014 Jun 19;123(25):3943-50. doi: 10.1182/blood-2013-07-514208. Epub 2014 May 12. Blood. 2014. PMID: 24820309 Free article.

2

Thrombopoietin production is inhibited by a translational mechanism.

Ghilardi N, Wiestner A, Skoda RC. Ghilardi N, et al. Among authors: skoda rc. Blood. 1998 Dec 1;92(11):4023-30. Blood. 1998. PMID: 9834204 Free article.

3

Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders.

Kralovics R, Buser AS, Teo SS, Coers J, Tichelli A, van der Maas AP, Skoda RC. Kralovics R, et al. Among authors: skoda rc. Blood. 2003 Sep 1;102(5):1869-71. doi: 10.1182/blood-2003-03-0744. Epub 2003 May 1. Blood. 2003. PMID: 12730106 Free article.

4

Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells.

Schomber T, Kalberer CP, Wodnar-Filipowicz A, Skoda RC. Schomber T, et al. Among authors: skoda rc. Blood. 2004 Jun 15;103(12):4511-3. doi: 10.1182/blood-2003-07-2397. Epub 2004 Feb 26. Blood. 2004. PMID: 14988151 Free article.

5

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.

Kralovics R, Teo SS, Buser AS, Brutsche M, Tiedt R, Tichelli A, Passamonti F, Pietra D, Cazzola M, Skoda RC. Kralovics R, et al. Among authors: skoda rc. Blood. 2005 Nov 15;106(10):3374-6. doi: 10.1182/blood-2005-05-1889. Epub 2005 Aug 4. Blood. 2005. PMID: 16081684 Free article.

6

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

Kralovics R, Teo SS, Li S, Theocharides A, Buser AS, Tichelli A, Skoda RC. Kralovics R, et al. Among authors: skoda rc. Blood. 2006 Aug 15;108(4):1377-80. doi: 10.1182/blood-2005-11-009605. Epub 2006 May 4. Blood. 2006. PMID: 16675710 Free article. Clinical Trial.

7

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera.

Lippert E, Boissinot M, Kralovics R, Girodon F, Dobo I, Praloran V, Boiret-Dupré N, Skoda RC, Hermouet S. Lippert E, et al. Among authors: skoda rc. Blood. 2006 Sep 15;108(6):1865-7. doi: 10.1182/blood-2006-01-013540. Epub 2006 May 25. Blood. 2006. PMID: 16728702 Free article.

8

Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo.

Tiedt R, Schomber T, Hao-Shen H, Skoda RC. Tiedt R, et al. Among authors: skoda rc. Blood. 2007 Feb 15;109(4):1503-6. doi: 10.1182/blood-2006-04-020362. Epub 2006 Oct 10. Blood. 2007. PMID: 17032923 Free article.

9

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Theocharides A, Boissinot M, Girodon F, Garand R, Teo SS, Lippert E, Talmant P, Tichelli A, Hermouet S, Skoda RC. Theocharides A, et al. Among authors: skoda rc. Blood. 2007 Jul 1;110(1):375-9. doi: 10.1182/blood-2006-12-062125. Epub 2007 Mar 15. Blood. 2007. PMID: 17363731 Free article.

10

Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice.

Pan D, Schomber T, Kalberer CP, Terracciano LM, Hafen K, Krenger W, Hao-Shen H, Deng C, Skoda RC. Pan D, et al. Among authors: skoda rc. Blood. 2007 Oct 15;110(8):3049-55. doi: 10.1182/blood-2007-02-074393. Epub 2007 Jul 16. Blood. 2007. PMID: 17638848 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters